Advanced Healthcare Materials · 2024 · 14 citations · 25 references
PharmacyImmunologyOncologyDrug DeliveryInflammationTumor MicroenvironmentCancer NanomedicineImmunotherapy For Solid TumorsNanomedicineTumor Immune MicroenvironmentTumor Microenvironment ModulationTumor-associated MacrophagesCancer Immunotherapy NanoparticlesCancer Photothermal TherapyCancer-associated MacrophagesInflammatory Microenvironment ModulationM2 Macrophage PhenotypesTumor Microenvironment EffectsTumor Microenvironment RegulationTumor-associated Inflammation
Achieving full eradication of residual tumors post photothermal therapy (PTT) hinges on the immune system's activation and response. Nevertheless, the resultant local inflammation attracts a significant influx of aberrant immune cells and fibroblasts, such as tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs), following tumor PTT. This phenomenon exacerbates immune evasion and the persistence of residual tumor cells, culminating in tumor recurrence and advancement. To tackle this challenge, a combined therapeutic approach utilizing multifunctional ICG-SB@Lip-ZA nanosystem has been introduced. Indocyanine green (ICG) as a photothermal-transducer ablated tumor cells, zoledronic acid (ZA) depletes TAMs recruited by the inflammatory tumor microenvironment (mostly M2-like phenotype), SB-505124 affects CAFs proliferation in the tumor microenvironment (TME) by inhibiting the transforming growth factor-β (TGF-β) pathway, thereby removing physical barriers to T cell infiltration. In a breast cancer model, these immunomodulatory nanoliposomes markedly decrease the population of M2-like TAMs in the TME, eliminate physical barriers hindering T cell infiltration, reshape the inflammatory immune-suppressive tumor microenvironment, eventually leading to a rate of tumor eradication of 94%. This multifunctional ICG-SB@Lip-ZA nanosystem (including photothermal conversion, TAM depletion, and TGF-β pathway blockade) offers a promising strategy for mitigating the deteriorating tumor microenvironment following PTT and presents a more efficient approach for clinical photothermal-immune combination therapy.
25
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin‐Zhi Qian, Jiufeng Li, Hui Zhang et al. · Nature · 2011 · 2.9K citations · Full text
Medicine, Cancer Biology, Oncology +14
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello, Sergio Palomo‐Ponce, Diana Stork et al. · Nature · 2018 · 1.8K citations
Medicine, Cancer Biology, Oncology +14
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Manfred Köpf, Heinz Baumann, Giulia Freer et al. · Nature · 1994 · 1.8K citations
Life Sciences, Immunology, Pathology +16